What is EVOQ Remedies share price return in the past 10 years?

Data is not available for this company

EVOQ Remedies Ltd - Stock Valuation and Financial Performance

Name: EVOQ Remedies
Brand: EVOQ Remedies

BSE: 543500 | NSE: | Trading | Small Cap

Place order

EVOQ Remedies Share Price

₹7.31 -0.19 -2.53%
as on 21-Nov'24 16:59

DeciZen - make an informed investing decision on EVOQ Remedies

Based on:

Data

M-Cap below 100cr DeciZen not available

EVOQ Remedies stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

41.32

Market Cap:

18.7 Cr.

52-wk low:

7.3

52-wk high:

19.4

Is EVOQ Remedies Ltd an attractive stock to invest in?

1. Is EVOQ Remedies Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that EVOQ Remedies Ltd is a average quality company.

2. Is EVOQ Remedies Ltd undervalued or overvalued?

The key valuation ratios of EVOQ Remedies Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is EVOQ Remedies Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of EVOQ Remedies Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of EVOQ Remedies:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	68.9%	2.7%	246.9%	9.1%	7%	1.9%	-
Value Creation Index ⓘ	3.9	-0.8	16.6	-0.4	-0.5	-0.9	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	3.3	9.1	10	16.8	20.4	4.1	4
Sales YoY Gr.	-	179.1%	10.5%	67.5%	21.5%	-80.1%	-
Adj EPS ⓘ	0.2	0	10.1	0.8	1.2	0.3	0.2
YoY Gr.	-	-100%	NA	-92.1%	48.8%	-72.3%	-
BVPS (₹) ⓘ	0	0	10.5	17	18.2	18.6	17.9
Adj Net Profit ⓘ	0	0	0.7	1.1	1.6	0.5	0
Cash Flow from Ops. ⓘ	0	0	0	-26.4	-4.4	5.3	-
Debt/CF from Ops. ⓘ	0.2	-0.3	0	-0.3	-2.2	0.8	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	4.5%	-26.1%	-80.1%
Adj EPS ⓘ	NA	15.6%	-68%	-72.3%
BVPSⓘ	NA	NA	21%	1.9%
Share Price	-	-	-	-39.6%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	49.8	1.3	186.9	9.1	6.8	1.8	1
Op. Profit Mgn % ⓘ	0.5	0	9.5	8.7	-18.3	-40.4	NAN
Net Profit Mgn % ⓘ	0.3	0	7.1	6.5	7.9	11.2	11.1
Debt to Equity ⓘ	0.1	0.3	0	0.4	0.4	0.2	-
Working Cap Days ⓘ	0	156	249	416	582	3,218	0
Cash Conv. Cycle ⓘ	0	-34	-38	268	402	1,008	0

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 1.00%

Sales growth has been subdued in last 3 years -26.06%

Net Profit has been subdued in last 3 years -68.01%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - EVOQ Remedies Ltd.

	Standalone	Consolidated
TTM EPS (₹)	0.2	-
TTM Sales (₹ Cr.)	4.1	-
BVPS (₹.) ⓘ	17.9	-
Reserves (₹ Cr.) ⓘ	20	-
P/BV ⓘ	0.42	-
PE ⓘ	41.32	-

From the Market
52 Week Low / High (₹)	7.30 / 19.44
All Time Low / High (₹)	7.30 / 25.00
Market Cap (₹ Cr.)	18.7
Equity (₹ Cr.)	24.9
Face Value (₹)	10
Industry PE ⓘ	69

Management X-Ray of EVOQ Remedies:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of EVOQ Remedies

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of EVOQ Remedies

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	3.25	9.07	10.02	16.78	20.39	4.05
Operating Expenses ⓘ	3.23	9.07	9.07	15.32	24.12	5.69
Manufacturing Costs	0	0	0.06	0.04	0.09	0.01
Material Costs	3.23	9.05	7.85	13.77	19.33	1.56
Employee Cost	0	0.01	0.01	0.18	0.20	0.08
Other Costs ⓘ	0.01	0.01	1.15	1.33	4.50	4.04
Operating Profit ⓘ	0.02	0	0.95	1.46	-3.73	-1.64
Operating Profit Margin (%)	0.5%	0.0%	9.5%	8.7%	-18.3%	-40.4%
Other Income ⓘ	0	0	0	0	6.02	2.26
Interest ⓘ	0	0	0	0	0	0
Depreciation ⓘ	0	0	0	0	0	0.01
Exceptional Items ⓘ	0	0	0	0	0	0
Profit Before Tax ⓘ	0.02	0	0.95	1.46	2.28	0.61
Tax ⓘ	0	0	0.24	0.37	0.67	0.16
Profit After Tax	0.01	0	0.72	1.09	1.62	0.45
PAT Margin (%)	0.3%	0.0%	7.1%	6.5%	7.9%	11.2%
Adjusted EPS (₹)	0.2	0.0	10.1	0.8	1.2	0.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	0.02	0.02	0.74	23.17	24.79	25.24
Share Capital ⓘ	0.01	0.01	0.01	13.60	13.60	13.60
Reserves ⓘ	0.01	0.01	0.73	9.57	11.19	11.64
Minority Interest	0	0	0	0	0	0
Debt	0	0.01	0	8.16	9.58	4.24
Long Term Debt	0	0.01	0	0	0	0
Short Term Debt	0	0	0	8.16	9.58	4.24
Trade Payables	2.12	5.62	6.78	1.21	-0.54	3.28
Others Liabilities ⓘ	0.01	0	0.52	0.80	1.07	4.10
Total Liabilities ⓘ	2.15	5.65	8.05	33.33	34.90	36.86
Fixed Assets
Gross Block	0	0	0	0	0.01	0.03
Accumulated Depreciation	0	0	0	0	0	0.01
Net Fixed Assetsⓘ	0	0	0	0	0.01	0.01
CWIP ⓘ	0	0	0	0	0	0
Investmentsⓘ	0	0	0	0	0	0
Inventories	0.03	0.06	0.15	0.78	2.03	3.13
Trade Receivables	1.23	4.72	6.84	25.40	17.22	1.74
Cash Equivalents	0.02	0	0.03	3.09	0.15	0.12
Others Assetsⓘ	0.87	0.87	1.03	4.06	15.49	31.86
Total Assets ⓘ	2.15	5.65	8.05	33.33	34.90	36.86

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	0.01	-0.02	0.03	-26.43	-4.35	5.32
PBT ⓘ	0.02	0	0.72	1.46	2.28	0.61
Adjustment ⓘ	0	0	0	0	0.01	0.01
Changes in Working Capital ⓘ	-0	-0.02	-0.68	-27.52	-5.97	4.86
Tax Paid ⓘ	0	0	0	-0.37	-0.67	-0.16
Cash Flow From Investing Activity ⓘ	0	0	0	0	-0.01	-0.01
Capex	0	0	0	0	-0.01	-0.01
Net Investments	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0
Cash Flow From Financing Activityⓘ	0	0	0	29.49	1.42	-5.34
Net Proceeds from Shares ⓘ	0	0	0	21.33	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0
Others ⓘ	0	0	0	8.16	1.42	-5.34
Net Cash Flow ⓘ	0.01	-0.02	0.03	3.06	-2.94	-0.03

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	49.78	1.34	186.89	9.13	6.75	1.81
ROCE (%)	68.94	2.69	246.9	9.12	6.96	1.92
Asset Turnover Ratio	1.51	2.33	1.46	0.81	0.6	0.11
PAT to CFO Conversion(x)	1	N/A	0.04	-24.25	-2.69	11.82
Working Capital Days
Receivable Days	138	120	210	351	381	854
Inventory Days	3	2	4	10	25	232
Payable Days	240	156	288	106	6	322

EVOQ Remedies Ltd Stock News

EVOQ Remedies Ltd FAQs

What is the share price of EVOQ Remedies?

Company share prices are keep on changing according to the market conditions. The closing price of EVOQ Remedies on 21-Nov-2024 16:59 is ₹7.31.

What is the market cap of EVOQ Remedies?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Nov-2024 16:59 the market cap of EVOQ Remedies stood at ₹18.68.

What is the P/E ratio of EVOQ Remedies?

The latest P/E ratio of EVOQ Remedies as of 21-Nov-2024 16:59 is 41.32.

What is the P/B ratio of EVOQ Remedies?

The latest P/B ratio of EVOQ Remedies as of 21-Nov-2024 16:59 is 0.42.

What is the 52-week high and low of EVOQ Remedies?

The 52-week high of EVOQ Remedies is ₹19.44 and the 52-week low is ₹7.30.

What is the TTM revenue of EVOQ Remedies?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of EVOQ Remedies is ₹4.05 ( Cr.) .

About EVOQ Remedies Ltd

EVOQ Remedies is one of the recognized trading house of Pharmaceuticals Raw Materials, Excipients, Bulk Drugs at affordable price catering to the customers located in Ahmedabad. It procures the pharmaceuticals Raw Materials products and chemicals from the suppliers which are having WHO-GMP approved production facilities in India and by focusing on its first-class distribution expertise.

In the area of Pharmaceuticals Raw Materials, Excipients, Bulk Drugs etc., the company is specializes in offering quality products and affordable trading in Gujarat. The company has a team of focused industry experts, who have in-depth knowledge of the industry and have with them expertise in offering best solutions for meeting their specific needs. It procure all the products from certified & reliable Manufacturers & Importers, who follow procedures as per the stringent national and international quality and safety standards. In order to achieve the task, it keep its regular visit to ensure quality and reliability of the products. Keeping its basic objective in mind, it strive hard to exceed all the expectations of its clients by supplying best quality products at the most reasonable prices. EVOQ is having its registered office, corporate office and storage location facilities located in Ahmedabad. In the healthcare segment, EVOQ being into trading business offers a wide basket of products.

EVOQ majorly does trading in following segments of pharmaceuticals raw materials:

Excipients
Nutraceuticals
Pellets
Solvents
Sweetners
Vitamins
Amino Acids
Bulk Drugs
Dairy Products
Active Pharmaceuticals Ingredients

Business area of the company

The company specializes in offering quality Pharmaceuticals Raw Material products, Excipients, and Bulk Drugs at an affordable prices.

Major events:

2010: Incorporation of Company as ‘Salus Life Science and Research Private Limited’ at Ahmedabad, Gujarat on February 24th, 2010 under the provisions of the Companies Act, 1956.
2021: Conversion of the Company into public limited company, the name of the company was changed to ‘Evoq Remedies Limited’ and fresh Certificate of Incorporation dated July 28, 2021 was issued by Registrar of Companies, Ahmedabad.